Peak Scientific Acquires Noblegen
Dusty TLP Ltd., the owner of Peak Scientific, has acquired Wirac Automation Ltd, a company that trades as Noblegen and specialises in the design, development, and manufacture of specialist gas and cryogenic solutions. This is the latest step in the Dusty TLP board’s vision to expand its portfolio and develop its range of products to better serve customers around the world, according to a press release issued by Peak Scientific.
Noblegen will remain a separate brand from Peak Scientific, and maintain its own identity. Noblegen will continue to operate independently, with the added support of the parent company. Paul Hudson, newly appointed General Manager for Noblegen, commented, “I am thrilled to take up this exciting opportunity with the team at Noblegen to continue bringing their existing customers the excellent products and customer service they have come to expect from Noblegen.”
Bill Johnston, founder of Wirac Automation Ltd, who will continue working at Noblegen in the role of Technical Director, added, “I’d like to thank all of our customers and suppliers who have been part of the business’s success over the years and I firmly believe that under the new ownership even greater successes are to be had in the years ahead.”
This article was written with the help of artificial intelligence and has been edited to ensure accuracy and clarity. You can read more about our policy for using AI here.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
